Login / Signup

Double-blind, Randomized, Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19).

Julio Cesar Garcia de AlencarClaudia de Lucena MoreiraAlicia Dudy MüllerCleuber Esteves ChavesMarina Akemi FukuharaElizabeth Aparecida da SilvaMaria de Fátima Silva MiyamotoVanusa Barbosa PintoCauê Gasparotto BuenoFelippe Lazar NetoLuz Marina Gomez GomezMaria Clara Saad MenezesJulio Flavio Meirelles MarchiniLucas Oliveira MarinoRodrigo Antônio Brandão NetoHeraldo Possolo de Souzanull null
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Brazilian Registry of Clinical Trials (REBEC): U1111-1250-356 (http://www.ensaiosclinicos.gov.br/rg/RBR-8969zg/).
Keyphrases
  • double blind
  • coronavirus disease
  • clinical trial
  • placebo controlled
  • phase iii
  • phase ii
  • open label
  • study protocol
  • respiratory syndrome coronavirus
  • sars cov
  • case report
  • randomized controlled trial
  • respiratory tract